Contract Research News
-
Quintiles shuts down India phase I unit
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 17 Oct, 2013
Singapore: Leading global contract research giant Quintiles has cited a challenging external business environment as the...Read more
-
Riken launches iPS cell therapy pilot study
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 01 Aug, 2013
Singapore: Riken has launched a pilot study to assess the safety and feasibility of the transplantation of autologous in...Read more
-
WHO demands transparency in clinical trial results
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 16 Apr, 2015
Singapore: In a study that analysed reports from large clinical trials (more than 500 participants), registered on Clini...Read more
-
Research capital will continue to flow eastward
Contract Research | Opinion | By BioSpectrum Bureau | 0 Comment | 24 May, 2012
Growth of the biotech industry in Singapore over the last 10 years has, in a number of measures, outpa...Read more
-
Biochips market to be worth $11.4 bn by 2018
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 09 Jul, 2013
Singapore: A recent report released by RnRMarketResearch.com has analyzed the Global Biochips Industry and forecasted th...Read more
-
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 02 Oct, 2014
Singapore: Pharma and biotech R&D service provider, WuXi PharmaTech, has acquired XenoBiotic Laboratories, a contrac...Read more
-
Charles River acquires microbe testing lab
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 06 Nov, 2013
Singapore: Charles River has acquired Brass, a Singapore-based microbiology subcontract test laboratory specializing in ...Read more
-
Australia to boost clinical trial landscape
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 22 Aug, 2014
Singapore: Australia's National Health and Medical Research Council (NHMRC) has taken up the task of implementing initia...Read more
-
WuXi PharmaTech appoints William Keller to Board
Contract Research | Influencers | By BioSpectrum Bureau | 0 Comment | 01 Oct, 2014
Singapore: China bioscience service provider, WuXi PharmaTech, has appointed Mr William Robert Keller as an independent ...Read more
-
Evolving trends in clinical trial designs
Contract Research | Opinion | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2014
In the current competitive era of drug development, establishing the superiority of a new medical intervention compared ...Read more
-
Strategic site selection could help reduce study delays
Contract Research | Opinion | By BioSpectrum Bureau | 0 Comment | 09 Oct, 2014
With surveys indicating that 70 percent of clinical trials across Asia, Europe, Canada and Latin America experience dela...Read more
-
Australian CRO Novotech opens new office in India
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 29 Jun, 2015
Singapore: Further expanding its presence in Asia, Australia's leading Contract Research Organization Novotech recently ...Read more
-
WuXi Pharma ventures into Israel
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 04 Nov, 2014
Singapore: China headquarterd WuXi PharmaTech has expanded its presence in Israel to provide integrated R&D services...Read more
-
Dishman might sell China plant to clear debts
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 13 Jan, 2014
Singapore: India's Ahmedabad based contract research and manufacturing services (CRAMS) company Dishman Pharmaceuticals ...Read more
-
Clinical Outsourcing Models: "Drive a Hybrid"
Contract Research | Opinion | By BioSpectrum Bureau | 0 Comment | 02 Jun, 2015
Singapore: When we think "hybrid" we think of taking the best components from often opposing approaches and forming a ne...Read more
-
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 02 Jul, 2014
Singapore: Parexel, a global clinical research organization with strong base in Asia, has acquired all outstanding equit...Read more
-
GVK announces successful completion of project
Contract Research | News | By BioSpectrum Bureau | 0 Comment | 22 Oct, 2014
Singapore: GVK biosciences has announced the successful completion of in-silico based alternative indications of shelved...Read more
-
USFDA issues haunts Jubilants's Q1 growth
Contract Research | Company results | By BioSpectrum Bureau | 0 Comment | 07 Aug, 2014
India: The board of Jubilant Life Sciences, an integrated pharmaceutical and lifesciences company met on August 06, 2014...Read more
